Effects of chronic treatment with the CB1 antagonist, rimonabant on the blood pressure, and vascular reactivity of obese Zucker rats (Q28574794)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Effects of chronic treatment with the CB1 antagonist, rimonabant on the blood pressure, and vascular reactivity of obese Zucker rats (English)

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

Maria Dolores Herrera Gonzalez

1 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

Carmen Mingorance

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

6

Elisa Marhuenda

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

Maria Álvarez de Sotomayor Paz

1 February 2020

2

object named as

María Alvarez de Sotomayor

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Cristina Casto

5

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Francisco J Jiménez-Palacios

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

19 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

17

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1340-1347

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

7

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

The metabolic syndrome--a new worldwide definition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Activation of the peripheral endocannabinoid system in human obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

The endocannabinoid system and cardiometabolic risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Mechanisms of endothelial dysfunction in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Endocannabinoid control of food intake and energy balance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Production and physiological actions of anandamide in the vasculature of the rat kidney.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Insulin and Obesity in the Zucker Genetically Obese Rat “Fatty”

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Exercise enhances vasorelaxation in experimental obesity associated hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Modulation of noradrenaline-induced vasoconstriction in isolated perfused mesenteric arterial beds from obese Zucker rats in the presence and absence of insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Argan (Argania spinosa) oil lowers blood pressure and improves endothelial dysfunction in spontaneously hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

The role of endocannabinoid system blockade in the treatment of the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissue- and CB1-receptor-specific mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Negative chronotropic effect of cannabinoids and their water-soluble emulsion is related to activation of cardiac CB1 receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

inferred from DOI database lookup

7 January 2021

based on heuristic

Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.20

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19553924%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2 references

31 January 2017